Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy

We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent maternal and neonatal complications of hyperglycemia.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • device : Dexcom Seven Plus Continuous Glucose Monitoring System

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - 50 Years

Inclusion Criteria

- 18 years of age or older - Receiving betamethasone as part of routine clinical care. - Pregnancy between 23+5 and 35+0 weeks

External Links

Explore related trials

Contact information

Primary Contact:

Yasser El-Sayed 6507233198

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: